Reference number : 236-2017-2018-Q1-00177, amendment number : , agreement type : G, recipient legal name : Hurskainen, Maria, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1Y 4E9, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 90000.0, agreement start date : 2017-07-01, agreement end date : 2019-06-30, description english : Novel therapies for surfactant protein deficiencies causing neonatal death and childhood lung fibrosis: Alveolar epithelial cells (AECs) derived from induced pluripotent cells (iPSCs) in therapy, description french : Novel therapies for surfactant protein deficiencies causing neonatal death and childhood lung fibrosis: Alveolar epithelial cells (AECs) derived from induced pluripotent cells (iPSCs) in therapy, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2019-20)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2019-20)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada